A case report of metastatic giant sarcomatoid melanoma with BRAF V600E mutation: a complete response to targeted therapy
Open Access
- 25 August 2020
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 11 (34) , 3256-3262
Abstract
Https://doi.org/10.18632/oncotarget.27701 Matteo Torresetti, Donatella Brancorsini, Francesca Morgese, Valeria Cognigni, Alessandro Scalise, Rossana Berardi, Giovanni Di BenedettoKeywords
This publication has 15 references indexed in Scilit:
- Living on the Edge: Diagnosing Sarcomatoid Melanoma Using Histopathologic Cues at the Edge of a Dedifferentiated Tumor: A Report of 2 Cases and Review of the LiteratureThe American Journal of Dermatopathology, 2017
- Exceptional Clinical Response to BRAF-Targeted Therapy in a Patient with Metastatic SarcomaCureus, 2015
- BRAF-mutated clear cell sarcoma is sensitive to vemurafenib treatmentInvestigational New Drugs, 2015
- Dramatic response of a BRAF V600E-mutated primary CNS histiocytic sarcoma to vemurafenibNeurology, 2014
- Desmoplastic Melanoma With Sarcomatoid DedifferentiationAmerican Journal of Surgical Pathology, 2014
- BRAF mutation in ‘sarcomas’: a possible method to detect de‐differentiated melanomasHistopathology, 2013
- Giant Scalp Melanoma: A Case Report and Review of the Literature2012
- Metastatic Desmoplastic Malignant Melanoma Associated With Low-Grade Myofibroblastic SarcomaThe American Journal of Dermatopathology, 2009
- Morphological and immunophenotypic variations in malignant melanomaHistopathology, 2000
- Malignant melanoma showing smooth muscle differentiation.Journal of Clinical Pathology, 1996